You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Gastroenterology

Importance of Assessing Multiple Disease Domains in EoE

Prof. Arjan Bredenoord and Dr. Evan Dellon emphasize the need to assess multiple disease domains to get the complete picture of patients’ EoE.

MD, PhD

Arjan Bredenoord +1 more

2 minutes

Learning objectives

Understand the importance of assessing symptoms, endoscopy, and histology when evaluating disease status in patients with EoE
Recognize the impact of different disease outcomes on patient burden

Description

Global experts Arjan Bredenoord, MD, PhD, and Evan Dellon, MD, MPH, emphasize the need to assess multiple disease domains to get the complete picture of a patient's EoE.

About these experts

Gastroenterology

MD, PhD

Arjan Bredenoord

Professor of Neurogastroenterology & Motility | University of Amsterdam, Netherlands; Consultant Gastroenterologist | Amsterdam University Medical Centers

Gastroenterology

MD, MPH

Evan Dellon

Professor of Medicine and Adjunct Professor of Epidemiology | University of North Carolina School of Medicine, Chapel Hill, United States

Related resources

Eosinophilic Esophagitis (EoE) Interactive Patient Case

Gastroenterology

10 min

interactivity

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Gastroenterology

12 min

audio

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Gastroenterology

5 min

Infographic

Adaptive Behaviors in EoE Infographic

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Importance of Assessing Multiple Disease Domains in EoE

Learning objectives

Description

About these experts

Arjan Bredenoord

Evan Dellon

Related resources

Eosinophilic Esophagitis (EoE) Interactive Patient Case

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease

Importance of Assessing Key Disease Domains in EoE Infographic

Pediatric EoE Disease Burden Infographic

Complex EoE Pathophysiology Beyond Esophageal Eosinophilia

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE

Food Bolus Impaction: An Opportunity to Diagnose EoE

Gap in Care Leads to Progression of Fibrosis in EoE

Impact of Delayed EoE Diagnosis on Disease Progression and QoL